4.8 Article

Mapping the human DC lineage through the integration of high-dimensional techniques

Journal

SCIENCE
Volume 356, Issue 6342, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aag3009

Keywords

-

Funding

  1. Singapore Immunology Network core funding
  2. Agency for Science, Technology and Research (A*STAR), Singapore
  3. A*STAR Graduate Scholarship
  4. Wellcome Trust [WT 107931/Z/15/Z]
  5. National Research Foundation Singapore [NMRC/BNIG/2026/2014]
  6. French National Research Agency [ANR-10-INSB-04, ANR-10-IDEX-0001-02 PSL, ANR-11-LABX-0043]
  7. Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS)
  8. Emmy-Noether fellowship of the German Research Foundation [SCHL 2116/1-1]
  9. Biomedical Research Council Singapore
  10. [Sonderforschungsbereich 645]
  11. [704]
  12. Wellcome Trust [107931/Z/15/Z] Funding Source: Wellcome Trust
  13. Agence Nationale de la Recherche (ANR) [ANR-11-LABX-0043] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

Dendritic cells (DC) are professional antigen-presenting cells that orchestrate immune responses. The human DC population comprises two main functionally specialized lineages, whose origins and differentiation pathways remain incompletely defined. Here, we combine two high-dimensional technologies-single-cell messenger RNA sequencing (scmRNAseq) and cytometry by time-of-flight (CyTOF)-to identify human blood CD123(+)CD33(+)CD45RA(+)DC precursors (pre-DC). Pre-DC share surface markers with plasmacytoid DC (pDC) but have distinct functional properties that were previously attributed to pDC. Tracing the differentiation of DC from the bone marrow to the peripheral blood revealed that the pre-DC compartment contains distinct lineage-committed subpopulations, including one early uncommitted CD123(high) pre-DC subset and two CD45RA(+)CD123(low) lineage-committed subsets exhibiting functional differences. The discovery of multiple committed pre-DC populations opens promising new avenues for the therapeutic exploitation of DC subset-specific targeting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available